gene editing

The continuing CRISPR patent saga
The continuing CRISPR patent saga
Endpoints
gene editing
CRISPR
patents
Flag link:
Intellia announced a new tool for gene editing. Academics said they rewrote history
Intellia announced a new tool for gene editing. Academics said they rewrote history
Endpoints
CRISPR
gene editing
Intellia Therapeutics
Flag link:
With all the buzz in gene therapy, Sanofi offloads two small molecule sickle cell programs from $11.6B buyout to Global Blood Therapeutics
With all the buzz in gene therapy, Sanofi offloads two small molecule sickle cell programs from $11.6B buyout to Global Blood Therapeutics
Endpoints
Sanofi
sickle cell disease
gene therapy
gene editing
Global Blood Therapeutics
Flag link:
UCSD spinout pursues gene therapy for chronic pain following positive data in mice
UCSD spinout pursues gene therapy for chronic pain following positive data in mice
Fierce Biotech
UCSD
chronic pain
non-opioid pain treatments
gene editing
Flag link:
Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline
Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline
BioPharma Dive
Caribou Biosciences
Jennifer Doudna
CRISPR
gene editing
Flag link:
Gene editing biotech Beam adds to drug delivery stable with $120M GuideTx buy
Gene editing biotech Beam adds to drug delivery stable with $120M GuideTx buy
Fierce Biotech
Beam Therapeutics
gene editing
drug delivery
Flag link:
Precision's one-time gene editing treatment lowers cholesterol in monkeys for 3 years
Precision's one-time gene editing treatment lowers cholesterol in monkeys for 3 years
Fierce Biotech
Precision Biosciences
gene therapy
gene editing
familial hypercholesterolemia
Flag link:
Ensoma debuts with $70M, Takeda deal to pursue off-the-shelf genomic medicines
Ensoma debuts with $70M, Takeda deal to pursue off-the-shelf genomic medicines
Fierce Biotech
Ensoma
Takeda
CRISPR
gene editing
genomic medicine
Flag link:
After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact
After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact
Fierce Biotech
AbbVie
Editas Medicine
CRISPR
Caribou Biosciences
gene editing
Flag link:
Beam, Verve stockpile cash as investors bank on gene editing progress
Beam, Verve stockpile cash as investors bank on gene editing progress
BioPharma Dive
Beam Therapeutics
Verve Therapeutics
gene editing
funding
Flag link:
Bold Predictions for Medtech in 2021
Bold Predictions for Medtech in 2021
Medical Devices and Diagnostics Industry
devices
Medtech
COVID-19
remote patient monitoring
telemedicine
home care
digital medicine
artificial intelligence
machine learning
robotic surgery
3D printing
Joe Biden
gene editing
microbiome
CAR-T
Flag link:
Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up
Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up
Endpoints
Takeda
gene editing
Japan
AnGes
EmendoBio
Flag link:
1st Patients To Get CRISPR Gene-Editing Treatment Continue To Thrive
1st Patients To Get CRISPR Gene-Editing Treatment Continue To Thrive
NPR
CRISPR
gene editing
sickle cell disease
Flag link:
Bayer powers gene-editing startup Metagenomi to $65M A round
Bayer powers gene-editing startup Metagenomi to $65M A round
Fierce Biotech
Metagenomi
Bayer
CRISPR
gene therapy
gene editing
Flag link:
Intellia, beginning treatment in CRISPR study, secures Gates Foundation backing
Intellia, beginning treatment in CRISPR study, secures Gates Foundation backing
BioPharma Dive
Intellia Therapeutics
CRISPR
gene editing
Gates Foundation
Flag link:
EdiGene raises $67M to take gene-editing therapies into humans
EdiGene raises $67M to take gene-editing therapies into humans
Fierce Biotech
EdiGene
gene editing
CAR-T
beta thalassemia
ET-01
ET-02
Flag link:
Jennifer Doudna’s New Gene Editing Company Launches With A $20 Million Round To Develop Genetic Medicines
Jennifer Doudna’s New Gene Editing Company Launches With A $20 Million Round To Develop Genetic Medicines
Forbes
Jennifer Doudna
gene editing
Scribe Therapeutics
ALS
Flag link:
Moderna lands $100M upfront in deals with Vertex, Chiesi
Moderna lands $100M upfront in deals with Vertex, Chiesi
Fierce Biotech
Moderna Therapeutics
cystic fibrosis
R&D
Vertex Pharmaceuticals
gene editing
Chiesi
Flag link:
Mammoth Biosciences Signs Exclusive Deal For Recently-Discovered Crispr Protein
Mammoth Biosciences Signs Exclusive Deal For Recently-Discovered Crispr Protein
Forbes
Mammoth Biosciences
gene editing
CRISPR
University of California Berkeley
Flag link:
AbbVie cuts Editas CRISPR pact it inherited from Allergan
AbbVie cuts Editas CRISPR pact it inherited from Allergan
Fierce Biotech
Editas Medicine
Allergan
AbbVie
gene editing
CRISPR
Flag link:

Pages